Financhill
Back

Novartis AG 10K Form

Buy
70

NVSEF
Novartis AG

Last Price:
104.95
Seasonality Move:
2.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVSEF News And Ratings

See the #1 stock for the next 7 days that we like better than NVSEF

NVSEF Financial Statistics

Sales & Book Value

Annual Sales: $46.66B
Cash Flow: $5.49B
Price / Cash Flow: 17.37
Annual Sales: $21.67
Price / Book: 4.89

Profitability

EPS (TTM): 8.53000
Net Income (TTM): $17.6B
Gross Margin: $34.19B
Return on Equity: 41.89%
Return on Assets: 17.33%

Novartis AG Earnings Forecast

Key Novartis AG Financial Ratios

  • The Gross Profit Margin over the past 26 years for NVSEF is 73.27%.
  • The Selling, General & Administrative Expenses for NVSEF have been equal to 26.83% of Gross Profit Margin.
  • The Research & Development expenses have been 24.37% of Revenue.
  • The Interest Expense is 5.76% of Operating Income.
  • The Net Earning history of NVSEF is 31.83% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 17 years.

Novartis AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: NVSEF
Website: novartis.com

Debt

Debt-to-Equity Ratio: 0.7
Current Ratio: 1.11
Quick Ratio: 0.79

Price-to-Earnings

Trailing P/E Ratio: 14.92
Forward P/E Ratio: 0

NVSEF Technical Analysis vs Fundamental Analysis

Buy
70
Novartis AG (NVSEF) is a Buy

Is Novartis AG a Buy or a Sell?

  • Novartis AG stock is rated a Buy
    The current Novartis AG [NVSEF] share price is $105.97. The Score for NVSEF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.